| - GRCh37:
- Chr11:6636197-6636198
- GRCh38:
- Chr11:6614966-6614967
| TPP1 | I484fs | Neuronal ceroid lipofuscinosis 2 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640052-6640054
- GRCh38:
- Chr11:6618821-6618823
| TPP1 | L61fs | Neuronal ceroid lipofuscinosis 2 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636672-6636673
- GRCh38:
- Chr11:6615441-6615442
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635790
- GRCh38:
- Chr11:6614559
| TPP1 | L560P | Neuronal ceroid lipofuscinosis 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr11:6639009
- GRCh38:
- Chr11:6617778
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (May 2, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637609
- GRCh38:
- Chr11:6616378
| TPP1 | Q338E | Neuronal ceroid lipofuscinosis 2 | Pathogenic (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637276-6637277
- GRCh38:
- Chr11:6616045-6616046
| TPP1 | S369fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637902
- GRCh38:
- Chr11:6616671
| TPP1 | Y292* | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638018
- GRCh38:
- Chr11:6616787
| TPP1 | Q254* | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638011
- GRCh38:
- Chr11:6616780
| TPP1 | S256* | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638255
- GRCh38:
- Chr11:6617024
| TPP1 | S213* | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638255-6638257
- GRCh38:
- Chr11:6617024-6617026
| TPP1 | S213fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638998-6638999
- GRCh38:
- Chr11:6617767-6617768
| TPP1 | L80fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637717
- GRCh38:
- Chr11:6616486
| TPP1 | E302* | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636762-6636763
- GRCh38:
- Chr11:6615531-6615532
| TPP1 | F393fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636739-6636740
- GRCh38:
- Chr11:6615508-6615509
| TPP1 | T400fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638967-6638975
- GRCh38:
- Chr11:6617736-6617744
| TPP1 | L88fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637600-6637601
- GRCh38:
- Chr11:6616369-6616370
| TPP1 | N341fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640089
- GRCh38:
- Chr11:6618858
| TPP1 | T50fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636689-6636691
- GRCh38:
- Chr11:6615458-6615460
| TPP1 | P417fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636725-6636726
- GRCh38:
- Chr11:6615494-6615495
| TPP1 | D405fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637609
- GRCh38:
- Chr11:6616378
| TPP1 | Q338* | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636771
- GRCh38:
- Chr11:6615540
| TPP1 | G390R | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640106
- GRCh38:
- Chr11:6618875
| TPP1 | E44* | Neuronal ceroid lipofuscinosis 2 | Pathogenic (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637722
- GRCh38:
- Chr11:6616491
| TPP1 | G300fs | Neuronal ceroid lipofuscinosis 2 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636696
- GRCh38:
- Chr11:6615465
| TPP1 | V415M | Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638390
- GRCh38:
- Chr11:6617159
| TPP1 | | Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2, not provided
| Uncertain significance (Apr 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6636548
- GRCh38:
- Chr11:6615317
| TPP1 | T427S | Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2, not provided
| Uncertain significance (May 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6637236
- GRCh38:
- Chr11:6616005
| TPP1 | S382N | Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2, not provided
| Uncertain significance (Jun 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6637605
- GRCh38:
- Chr11:6616374
| TPP1 | R339L | not provided, Neuronal ceroid lipofuscinosis 2 | Conflicting interpretations of pathogenicity (Jul 22, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:6636300
- GRCh38:
- Chr11:6615069
| TPP1 | | Autosomal recessive spinocerebellar ataxia 7, not provided, Neuronal ceroid lipofuscinosis 2
| Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6635843
- GRCh38:
- Chr11:6614612
| TPP1 | W542* | Neuronal ceroid lipofuscinosis 2, not provided | Pathogenic (Jan 16, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6637632-6637634
- GRCh38:
- Chr11:6616401-6616403
| TPP1 | E329del | Neuronal ceroid lipofuscinosis 2 | Pathogenic (Jan 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637653
- GRCh38:
- Chr11:6616422
| TPP1 | V323A | not provided | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636153
- GRCh38:
- Chr11:6614922
| TPP1 | P499T | not provided | Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6637723
- GRCh38:
- Chr11:6616492
| TPP1 | G300R | not provided | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636446
- GRCh38:
- Chr11:6615215
| TPP1 | V461L | not provided | Uncertain significance (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637887
- GRCh38:
- Chr11:6616656
| TPP1 | | not provided | Uncertain significance (Jan 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638300
- GRCh38:
- Chr11:6617069
| TPP1 | L198P | not provided | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640437
- GRCh38:
- Chr11:6619206
| TPP1 | Q27E | not provided | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637976
- GRCh38:
- Chr11:6616745
| TPP1 | R268W | not provided | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640440
- GRCh38:
- Chr11:6619209
| TPP1 | D26N | not provided | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640428
- GRCh38:
- Chr11:6619197
| TPP1 | T30A | not provided | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637629
- GRCh38:
- Chr11:6616398
| TPP1 | S331Y | not provided | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637975
- GRCh38:
- Chr11:6616744
| TPP1 | R268Q | not provided | Uncertain significance (Aug 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6638027
- GRCh38:
- Chr11:6616796
| TPP1 | F251L | not provided, Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Oct 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6638091
- GRCh38:
- Chr11:6616860
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Pathogenic (Feb 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636487
- GRCh38:
- Chr11:6615256
| TPP1 | R447P | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Feb 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640505
- GRCh38:
- Chr11:6619274
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr11:6640503
- GRCh38:
- Chr11:6619272
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Aug 17, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr11:6640481
- GRCh38:
- Chr11:6619250
| TPP1 | A12V | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Apr 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr11:6640465
- GRCh38:
- Chr11:6619234
| TPP1 | | not provided | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638522
- GRCh38:
- Chr11:6617291
| TPP1 | | not provided | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638379
- GRCh38:
- Chr11:6617148
| TPP1 | G172R | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Apr 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr11:6637971
- GRCh38:
- Chr11:6616740
| TPP1 | | not provided | Likely benign (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6637291
- GRCh38:
- Chr11:6616060
| TPP1 | G364R | not provided | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636214
- GRCh38:
- Chr11:6614983
| TPP1 | | not provided | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635899
- GRCh38:
- Chr11:6614668
| TPP1 | E524K | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Apr 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr11:6637935
- GRCh38:
- Chr11:6616704
| TPP1 | M281I | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638360
- GRCh38:
- Chr11:6617129
| TPP1 | P178fs | Neuronal ceroid lipofuscinosis 2 | Likely pathogenic (Oct 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637541
- GRCh38:
- Chr11:6616310
| TPP1 | | not provided | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636205
- GRCh38:
- Chr11:6614974
| TPP1 | F481L | not provided | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637656
- GRCh38:
- Chr11:6616425
| TPP1 | T322I | not provided | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637732
- GRCh38:
- Chr11:6616501
| TPP1 | R297W | not provided, Neuronal ceroid lipofuscinosis 2 | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:6640621
- GRCh38:
- Chr11:6619390
| TPP1 | Q4L | not provided | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6639015
- GRCh38:
- Chr11:6617784
| TPP1 | | not provided | Likely benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637544
- GRCh38:
- Chr11:6616313
| TPP1 | | not provided | Pathogenic (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637587
- GRCh38:
- Chr11:6616356
| TPP1 | M345T | not provided | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6640149
- GRCh38:
- Chr11:6618918
| TPP1 | | not provided | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638008
- GRCh38:
- Chr11:6616777
| TPP1 | V257A | not provided | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638392
- GRCh38:
- Chr11:6617161
| TPP1 | | not provided | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6636669
- GRCh38:
- Chr11:6615438
| TPP1 | | not provided | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638943
- GRCh38:
- Chr11:6617712
| TPP1 | | not provided | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635806
- GRCh38:
- Chr11:6614575
| TPP1 | A555T | not provided | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637618
- GRCh38:
- Chr11:6616387
| TPP1 | A335T | not provided, Inborn genetic diseases | Uncertain significance (Feb 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6638358
- GRCh38:
- Chr11:6617127
| TPP1 | T179S | not provided | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634299
- GRCh38:
- Chr11:6613068
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634269
- GRCh38:
- Chr11:6613038
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634237
- GRCh38:
- Chr11:6613006
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634217
- GRCh38:
- Chr11:6612986
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635931
- GRCh38:
- Chr11:6614700
| TPP1 | | not provided, Neuronal ceroid lipofuscinosis 2 | Conflicting interpretations of pathogenicity (Nov 1, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:6635653
- GRCh38:
- Chr11:6614422
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635606
- GRCh38:
- Chr11:6614375
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635554
- GRCh38:
- Chr11:6614323
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634036
- GRCh38:
- Chr11:6612805
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635431
- GRCh38:
- Chr11:6614200
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635073
- GRCh38:
- Chr11:6613842
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635061
- GRCh38:
- Chr11:6613830
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634948
- GRCh38:
- Chr11:6613717
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634840
- GRCh38:
- Chr11:6613609
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634793
- GRCh38:
- Chr11:6613562
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6635536
- GRCh38:
- Chr11:6614305
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Benign (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6637628
- GRCh38:
- Chr11:6616397
| TPP1 | | Neuronal ceroid lipofuscinosis 2, not provided | Conflicting interpretations of pathogenicity (Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:6634669
- GRCh38:
- Chr11:6613438
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634527
- GRCh38:
- Chr11:6613296
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6634495
- GRCh38:
- Chr11:6613264
| TPP1 | | Neuronal ceroid lipofuscinosis 2 | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638914
- GRCh38:
- Chr11:6617683
| TPP1 | A108V | not provided | Conflicting interpretations of pathogenicity (Sep 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:6638559
- GRCh38:
- Chr11:6617328
| TPP1 | Q161* | not provided, Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis | Pathogenic/Likely pathogenic (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:6637552
- GRCh38:
- Chr11:6616321
| TPP1 | A357P | not provided | Uncertain significance (Oct 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6638988
- GRCh38:
- Chr11:6617757
| TPP1 | E83D | not provided | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |